Eftyhia Vardas

Eftyhia Vardas FC Path bụ prọfesọ pụrụ iche na nkà mmụta ọgwụ na ngalaba nke Medical Virology, Mahadum Stellenbosch, nakwa onyeisi nke virology na Lancet Laboratories na Johannesburg. Ọ bụ onye otu Kọmitii Ndụmọdụ Minista nke COVID-19 na minista ahụike South Africa.

Mmụta

Vardas gụsịrị akwụkwọ na Mahadum nke Witwatersrand (UoW) na BSc na physiology ahụike ma mesịa nata MBBCh ya, DTM&H na DPH sochiri ya./<

Ọrụ

Ọ gụrụ akwụkwọ ọkachamara ya na National Institutes of Communicable diseases na South Africa ma nwetakwa asambodo dịka onye otu South African College of Pathologists na clinical virology.^[1] O nwetara diplọma na ọgwụ na ịdị ọcha nke ebe okpomọkụ, ahụike ọha na eze site na UoW na modeling ọrịa na-efe efe site na London School of Tropical Hygiene and Medicine . ^[2]

Vardas bụ onye otu Kọmitii ndụmọdụ COVID-19 nke Minista ahụike nke South Africa.^[1]^[2] Ọ bụ prọfesọ pụrụ iche na-akwanyere ùgwù na nkà mmụta ọgwụ na Ngalaba nke Virology, Mahadum Stellenbosch, na onye isi nke virology na Lancet Laboratories nke Johannesburg, ebe, n'ọnwa Nọvemba n'afọ 2021, nchọpụta nke nje SARS-CoV-2 ọhụrụ dugara na nchọpụta nke Omicron. ^[3]^[4]

Nnyocha ya gara aga gụnyere nnwale maka ịmepụta ọgwụ mgbochi ọrịa HIV / AIDS, ^[5] ọgwụ mgbochi ịba ọcha n'anya B na ọgwụ mgbochi nje virus nke mmadụ. ^[1]

Ọrụ ndị ọzọ

N'afọ 2009, o ruru eru maka diplọma nke Cape Wine Master na edemede akpọrọ "Ọda na ịrị elu nke Sémillon na South Africa". ^[6] ^[7]

Akwụkwọ ndị a họọrọ

Giuliano, Anna R.; Palefsky, Joel M.; Goldstone, Stephen; Moreira, Edson D.; Penny, Mary E.; Aranda, Carlos; Vardas, Eftyhia; Moi, Harald; Jessen, Heiko; Hillman, Richard; Chang, Yen-Hwa; Ferris, Daron; Rouleau, Danielle; Bryan, Janine; Marshall, J. Brooke; Vuocolo, Scott; Barr, Eliav; David; Haupt, Richard M.; Guris, Dalya (3 Febụwarị 2011). "Ọrụ nke Quadrivalent HPV Vaccine megide ọrịa HPV na ọrịa na ụmụ nwoke". New England Journal of Medicine. 364 (5): 401–411. doi:10.1056/NEJMoa0909537. ISSN 0028-4793. PMC 3495065. [Ihe e dere n'ala ala peeji] (Onye so dee ya) Giuliano (3 February 2011). "Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males". New England Journal of Medicine 364 (5): 401–411. DOI:10.1056/NEJMoa0909537. ISSN 0028-4793. PMID 21288094.
[Ihe e dere n'ala ala peeji] [Ihe e dere n'ala ala peeji] "Ọdịdị nke Papillomavirus nke mmadụ n'èzí na ihe ndị metụtara ya n'etiti ụmụ nwoke na ụmụ nwanyị na kọntinent ise". Akwụkwọ akụkọ nke ọrịa na-efe efe. 203 (1): 58–65. doi:10.1093/infdis/jiq015. ISSN 0022-1899. PMC 3086430. PMID 21148497. (Onye so dee ya) Vardas (1 January 2011). "External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents". The Journal of Infectious Diseases 203 (1): 58–65. DOI:10.1093/infdis/jiq015. ISSN 0022-1899. PMID 21148497.
Hillman, Richard J.; Giuliano, Anna R.; Palefsky, Joel M.; Goldstone, Stephen; Moreira, Edson D.; Vardas, Eftyhia; Aranda, Carlos; Jessen, Heiko; Ferris, Daron G.; Coutlee, Francois; Marshall, J. Brooke; Vuocolo, Scott; Haupt, Richard M.; Guris, Dalya; Garner, Elizabeth I. O. (7 Disemba 2011). "Immunogenicity nke Quadrivalent Human Papillomavirus (Type 6/11/16/18) Ọgwụ mgbochi na ụmụ nwoke 16 ruo 26 afọ". Clinical na Vaccine Immunology. 19 (2): 261–267. doi:10.1128/CVI.05208-11. PMC 3272915. PMID 22155768. (Onye so dee ya) Hillman (7 December 2011). "Immunogenicity of the Quadrivalent Human Papillomavirus (Type 6/11/16/18) Vaccine in Males 16 to 26 Years Old" (in EN). Clinical and Vaccine Immunology 19 (2): 261–267. DOI:10.1128/CVI.05208-11. PMID 22155768.

Edemsibịa

Njikọ mpụga

Eftyhia Vardas Researchgate
"Work on a pioneering vaccine begins Living with AIDS # 253", Health-e News, 5 April 2006. Retrieved on 7 January 2022.

1 2 3 Eftyhia Vardas (en). The Conversation. Retrieved on 2022-01-03."Eftyhia Vardas". The Conversation. Retrieved 3 January 2022.
1 2 Prof Eftyhia Vardas (en-US). WCIM 2018. Archived from the original on 2023-12-11. Retrieved on 2022-01-03.. WCIM 2018. Retrieved 3 January 2022.
↑ Trial of potentially variant-proof vaccine ongoing in Western Cape | Institute Of Infectious Disease and Molecular Medicine (en). www.idm.uct.ac.za. Retrieved on 2022-01-03.
↑ "Inside the South African lab that discovered Omicron", Africanews. Retrieved on 7 January 2022. (in en)
↑ Abbott. "Therapeutic HIV vaccines show promise", Scientific American, 27 July 2020. Retrieved on 7 January 2022. (in en)
↑ Vardas, Eftyhia (Prof) | Institute of Cape Wine Masters. www.icwm.co.za. Retrieved on 7 January 2022.
↑ Five new Cape Wine Masters graduate (en). wine.co.za (13 May 2009). Retrieved on 7 January 2022.

[Conv-1] 1 2 3 Eftyhia Vardas (en). The Conversation. Retrieved on 2022-01-03."Eftyhia Vardas". The Conversation. Retrieved 3 January 2022.

[WCIM-2] 1 2 Prof Eftyhia Vardas (en-US). WCIM 2018. Archived from the original on 2023-12-11. Retrieved on 2022-01-03.. WCIM 2018. Retrieved 3 January 2022.

[3] Trial of potentially variant-proof vaccine ongoing in Western Cape | Institute Of Infectious Disease and Molecular Medicine (en). www.idm.uct.ac.za. Retrieved on 2022-01-03.

[AN-4] "Inside the South African lab that discovered Omicron", Africanews. Retrieved on 7 January 2022. (in en)

[Abbott2020-5] Abbott. "Therapeutic HIV vaccines show promise", Scientific American, 27 July 2020. Retrieved on 7 January 2022. (in en)

[CWM-6] Vardas, Eftyhia (Prof) | Institute of Cape Wine Masters. www.icwm.co.za. Retrieved on 7 January 2022.

[7] Five new Cape Wine Masters graduate (en). wine.co.za (13 May 2009). Retrieved on 7 January 2022.

[1]

[2]

[3]

[4]

[5]

[6]

[7]